FR2073358B1 - - Google Patents

Info

Publication number
FR2073358B1
FR2073358B1 FR7040685A FR7040685A FR2073358B1 FR 2073358 B1 FR2073358 B1 FR 2073358B1 FR 7040685 A FR7040685 A FR 7040685A FR 7040685 A FR7040685 A FR 7040685A FR 2073358 B1 FR2073358 B1 FR 2073358B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7040685A
Other versions
FR2073358A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2073358A1 publication Critical patent/FR2073358A1/fr
Application granted granted Critical
Publication of FR2073358B1 publication Critical patent/FR2073358B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18611Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18711Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
FR7040685A 1969-11-14 1970-11-13 Expired FR2073358B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87702769A 1969-11-14 1969-11-14

Publications (2)

Publication Number Publication Date
FR2073358A1 FR2073358A1 (fr) 1971-10-01
FR2073358B1 true FR2073358B1 (fr) 1974-02-22

Family

ID=25369101

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7040685A Expired FR2073358B1 (fr) 1969-11-14 1970-11-13

Country Status (5)

Country Link
AU (1) AU2183370A (fr)
DE (1) DE2056051A1 (fr)
FR (1) FR2073358B1 (fr)
GB (1) GB1270918A (fr)
NL (1) NL7015493A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358438A (en) * 1979-07-17 1982-11-09 Gist-Brocades N.V. Novel polyvalent virus vaccine against rabies and canine distemper
GB2053679A (en) * 1979-07-17 1981-02-11 Gist Brocades Nv Rabies/canine distemper vaccines
US4657761A (en) * 1985-06-05 1987-04-14 Pinto Cesar M Polyvalent non-specific immuno-stimulating vaccine and method
AU762857B2 (en) * 1999-04-20 2003-07-10 Smithkline Beecham Biologicals (Sa) Vaccine
WO2005017201A1 (fr) * 2003-08-01 2005-02-24 University Of South Florida Methode permettant de traiter des infections par le virus de l'herpes

Also Published As

Publication number Publication date
FR2073358A1 (fr) 1971-10-01
DE2056051A1 (de) 1971-05-27
GB1270918A (en) 1972-04-19
AU2183370A (en) 1972-05-04
NL7015493A (fr) 1971-05-18

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU450150B2 (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442380B2 (fr)
AU442535B2 (fr)
AU442538B2 (fr)
AU442554B2 (fr)
AU442322B2 (fr)
FR2044586A5 (fr)
AT308690B (fr)
AU470661B1 (fr)
AU442357B2 (fr)
AU5077469A (fr)
AU4949169A (fr)
AU4540468A (fr)
AU5228269A (fr)
AR203167Q (fr)
AU5109569A (fr)
AU5079269A (fr)
AU480213A (fr)
CH1840069A4 (fr)
AU4982068A (fr)
AU4953367A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse